Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trialMasatoshi Kudo, Yasuaki Arai, Kazuomi Ueshima et al.|Gut|2019Cited by 720
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Shiv Kumar Sarin, Ashok Choudhury, George Lau et al.|Hepatology International|2020Cited by 295
Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinomaTetsuhiro Chiba, Osamu Yokosuka|International Journal of Cancer|2014Cited by 117
New antiviral therapies for chronic hepatitis CTatsuo Kanda, Osamu Yokosuka|Hepatology International|2010Cited by 105
Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent MannersTetsuhiro Chiba, Osamu Yokosuka|PLoS ONE|2014Cited by 79